BSV:NYE-Vanguard Short-Term Bond Index Fund ETF Shares (USD)

ETF | Short-Term Bond |

Last Closing

USD 77.91

Change

-0.13 (-0.17)%

Market Cap

N/A

Volume

3.94M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-07 )

Largest Industry Peers for Short-Term Bond

Symbol Name Price(Change) Market Cap
SPSB SPDR Barclays Short Term Corpo..

-0.04 (-0.13%)

USD 7.71B
LDUR PIMCO Enhanced Low Duration Ac..

-0.05 (-0.05%)

USD 0.85B
FLTB Fidelity® Limited Term Bond E..

-0.06 (-0.12%)

USD 0.16B
IIGD Invesco Investment Grade Defen..

-0.04 (-0.14%)

USD 0.04B
NUSA Nuveen Enhanced Yield 1-5 Year..

-0.04 (-0.15%)

USD 0.03B
LSST Natixis Loomis Sayles Short Du..

N/A

N/A

ETFs Containing BSV

TBFC The Brinsmere Fund - Cons.. 8.51 % 0.00 %

-0.05 (-0.17%)

N/A
SNUG 0.00 % 0.00 %

N/A

N/A
CLSA 0.00 % 0.00 %

N/A

N/A
CLSC 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Short-Term Bond) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.16% 86% B+ 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.16% 86% B+ 35% F
Trailing 12 Months  
Capital Gain 3.59% 86% B+ 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.59% 86% B+ 29% F
Trailing 5 Years  
Capital Gain -3.84% 86% B+ 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.84% 86% B+ 46% F
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike